Earnings Alerts

Blowing Past Predictions: Taiwan Cement (1101) Earnings Surpass Estimates in 1Q Net Income

  • Taiwan Cement‘s net income for the 1Q beat estimates, reaching NT$1.96 billion compared to the estimated NT$1.38 billion based on two estimates.

  • The company’s operating profit was NT$1.20 billion, slightly below the estimated figure of NT$1.36 billion.

  • Revenue surpassed forecasts, with Taiwan Cement earning NT$25.54 billion, over the estimated NT$22.17 billion.

  • EPS (Earnings Per Share) also exceeded predictions, with actual EPS being NT$0.26 as opposed to the estimated NT$0.21 based on earlier forecasts.

  • The current market sentiment shows 3 buys, 5 holds, and 1 sell on Taiwan Cement‘s stock positioning.


A look at Taiwan Cement Smart Scores

FactorScoreMagnitude
Value5
Dividend2
Growth2
Resilience3
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

“`html

According to Smartkarma Smart Scores, Taiwan Cement shows a strong value proposition with a top score of 5, indicating it may be undervalued compared to its peers. However, the company’s dividend and growth potential receive moderate scores of 2 each, suggesting room for improvement in these areas. In terms of resilience and momentum, Taiwan Cement scores 3, reflecting a steady performance and average market momentum.

Taiwan Cement Corporation, known for manufacturing and marketing various types of cement including Portland cement and high-strength cement, demonstrates diversified operations across transportation, construction, and information products through its subsidiaries. While the company boasts solid value metrics, investors might seek higher dividends and growth prospects to further enhance its long-term outlook.

“`


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars